PRINCETON, N. J., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Teclison, Inc., a clinical-stage oncology company dedicated to advancing immunotherapeutic treatments for solid tumors, today announced that Ray Lee ...

Upper gastrointestinal (GI) cancers include cancer of the esophagus (the tube that carries food from the mouth to the stomach), the stomach, and the small intestine. These cancers can sometimes be ...

DEM BioPharma, Inc. (DEM Bio), a biopharmaceutical company dedicated to discovering novel targets for solid tumors and ...

Note: Articles may be assigned to more than one subject area, as a result the sum of the subject research outputs may not equal the overall research outputs. Identify research insights to guide ...

Treatment of gastrointestinal (GI) cancers is catching up with other areas of oncology and offering patients better prospects for survival and quality of life, but a significant uptick in early-onset ...

Treatment for upper gastrointestinal (GI) cancers depends on several factors, including the type, location, and stage of the cancer (how far it has advanced). Treatments may include surgery, ...

Dr. John Gaetano performs a colonoscopy on Mike Lowe, 45, at Northwestern Lake Forest Hospital on April 18. (Stacey Wescott / Chicago Tribune via Getty Images file) Gastrointestinal cancers, which ...

GLP-1 drugs are 36% more effective than aspirin in reducing colorectal cancer risk, with fewer side effects like acute kidney ...

Gastrointestinal cancer represents a complex group of diseases that affect the digestive system, claiming hundreds of thousands of lives globally each year. These malignancies can develop anywhere ...

– Data Support the Ongoing Phase 3 STAR-221 Study of Domvanalimab Plus Zimberelimab and Chemotherapy, Potentially the First Anti-TIGIT Combination to Market for These Cancers – FOSTER CITY, Calif. & ...